We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

227 hedge funds and large institutions have $2.31B invested in Ironwood Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 84 increasing their positions, 70 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $2.87M

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

20% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 70

9% more funds holding

Funds holding: 208 → 227 (+19)

1.17% more ownership

Funds ownership: 107.75% → 108.92% (+1.2%)

3% more capital invested

Capital invested by funds: $2.24B → $2.31B (+$69M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
227
Holders Change
+19
Holders Change %
+9.13%
% of All Funds
3.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
84
Reduced
70
Closed
17
Calls
$13.1M
Puts
$2.87M
Net Calls
+$10.3M
Net Calls Change
-$1.35M

Top Buyers

1
LSV Asset Management
LSV Asset Management
Illinois
+$44.6M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$25.9M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$24.8M
4
BlackRock
BlackRock
New York
+$11.9M
5
FP
Foundry Partners
Minnesota
+$11.5M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$46.4M
2
CCM
Camber Capital Management
Massachusetts
-$25.8M
3
BCM
Brown Capital Management
Maryland
-$19.1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$15.9M
5
BM
Bridger Management
New York
-$13.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$17.3M +$4.41M +341,189 +35%
Wells Fargo
27
Wells Fargo
California
$16.9M +$4.35M +336,513 +35%
UBS AM
28
UBS AM
Illinois
$16.1M -$8.74M -676,165 -35%
GT
29
Glenmede Trust
Pennsylvania
$14.3M -$67.2K -5,203 -0.5%
PAMS
30
Pictet Asset Management (Switzerland)
Switzerland
$13.5M +$13.4M +1,033,687 New
BM
31
Bridger Management
New York
$12.7M -$13.8M -1,064,600 -52%
GLA
32
Great Lakes Advisors
Illinois
$12.5M -$399K -30,897 -3%
FP
33
Foundry Partners
Minnesota
$11.7M +$11.5M +893,070 New
Prudential Financial
34
Prudential Financial
New Jersey
$11.3M +$2.41M +186,469 +28%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$10.4M -$341K -26,376 -3%
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$9.61M +$9.51M +735,721 New
Invesco
37
Invesco
Georgia
$9.16M -$167K -12,924 -2%
HP
38
HealthInvest Partners
Sweden
$8.95M -$10.8M -835,000 -55%
1M
39
13D Management
New York
$8.49M – – –
UBS Group
40
UBS Group
Switzerland
$8.13M +$2.99M +231,156 +59%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$7.87M +$6.24M +483,000 +403%
IM
42
Islet Management
New York
$7.84M +$1.29M +100,000 +20%
ECM
43
ExodusPoint Capital Management
New York
$7.59M +$2.44M +188,644 +48%
MFP
44
Michael F. Price
$6.79M – – –
Federated Hermes
45
Federated Hermes
Pennsylvania
$6.53M +$251K +19,425 +4%
Comerica Bank
46
Comerica Bank
Texas
$6.51M -$260K -20,110 -4%
PPA
47
Parametric Portfolio Associates
Washington
$6.05M +$1.16M +89,669 +24%
Squarepoint
48
Squarepoint
New York
$5.56M +$3.8M +293,762 +223%
Deutsche Bank
49
Deutsche Bank
Germany
$5.32M +$3.98M +307,728 +308%
Bank of America
50
Bank of America
North Carolina
$5.26M +$217K +16,822 +4%
1
2
3 4 5

IRWD Hedge Fund Activity: Q3 2021 in Review

227 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2021, worth a combined $2.31B — up 3.1% from $2.24B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IRWD positions and 17 closed out — a net gain of 21 holders — while 84 added to existing stakes and 70 trimmed.

The largest buyer was LSV Asset Management, adding an estimated $44.6M. The largest seller was Wellington Management Group, cutting an estimated $46.4M.

  • 227 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2021, up from 208 in Q2 2021.
  • Funds reported $2.31B of Ironwood Pharmaceuticals stock for Q3 2021, up 3.1% quarter-over-quarter.
  • 38 funds opened new Ironwood Pharmaceuticals positions in Q3 2021 and 17 closed out, a net change of +21 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2021 was LSV Asset Management, an estimated $44.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2021 was Wellington Management Group, an estimated $46.4M sold.

Based on aggregated 13F filings for Q3 2021.